- Report
- January 2026
- 182 Pages
Global
From €3129EUR$3,545USD£2,727GBP
€3476EUR$3,939USD£3,030GBP
- Report
- January 2026
- 292 Pages
Global
From €2206EUR$2,500USD£1,923GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,454GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more